InvestSMART

EVE Health Group Limited (ASX:EVE)

ALERT: Price-sensitive ASX Announcement for EVE
Current share price for EVE : $0.017 -0.014 (-45.16%)+
Announcement
Release
28 Apr 2026 8:15AM
Price at Release
$0.031
Full Release
download
Summary
EVE Health Group Limited has announced the appointment of Mr. Ben Rohr as the new Chief Executive Officer, effective immediately. Mr. Rohr, who has been part of the company as the Chief Operating Officer, has played a vital role in the company’s operational success and strategic execution. His new role aligns with the company's focus on accelerating the commercialization of its product portfolio. Mr. Damian Wood, the outgoing CEO, will transition to the role of Head of Regulatory and Medical Affairs. This leadership restructuring is aimed at aligning the company's executive capabilities with its strategic goals, highlighting a strong emphasis on regulatory and commercial growth. The full executive arrangement details are provided in the company's appendix.
Key Points
  • Appointment of Ben Rohr as CEO, effective immediately.
  • Ben Rohr previously served as Chief Operating Officer.
  • Damian Wood transitions to Head of Regulatory and Medical Affairs.
  • Leadership restructuring to align with strategic priorities.
  • Focus on accelerating commercialization of product portfolio.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.